Physician profile
Brandy L Benjamin
NPI 1689000366
$1,027.51
in general payments reported to CMS, 2019-2025
14 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $114 · 2022: $19.75 · 2023: $316 · 2024: $189 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $893.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $180.11 | 2023-2025 | Belbuca, Xtampza |
| Janssen Pharmaceuticals, INC | $173.02 | 2023-2025 | Spravato |
| Abbvie INC. | $163.55 | 2021-2025 | |
| Vertex Pharmaceuticals Incorporated | $103.98 | 2024-2025 | |
| Medtronic, INC. | $99.26 | 2025 | Inceptiv, Rf Conductr Mc |
| Averitas Pharma INC. | $94.23 | 2025 | Qutenza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.81 | 2023-2024 | Relistor |
| Teva Pharmaceuticals USA, INC. | $29.44 | 2023 | Ajovy |
| Si-Bone, INC. | $26.63 | 2024 | |
| Abbott Laboratories | $24.15 | 2025 | Proclaim |
| Spr Therapeutics, INC | $24.10 | 2023-2025 | Sprint Pns System |
| Redhill Biopharma INC. | $23.21 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.75 | 2022 | |
| Pfizer INC. | $18.27 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Benjamin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.